It is common knowledge that not all parts of the world benefit from the outstanding waves of technological or medical revolutions most of us witness daily. You don’t need to necessarily think about very remote places, secluded islands or isolated tribes because taking a look at underdeveloped countries or even certain areas of your own country are enough to understand that beyond the gift of life that we all have been given, some of us had the privilege of being born in places that can offer easy access to healthcare, the benefits of technological progress and more. Now what about the rest of the world? What about those parts where getting a full set of blood tests or even the most common medical check-up seems like something out of the ordinary and where living with an undiagnosed disease for years on end is just a normal part of life?
“The diagnostic machine incorporates several functions a normal laboratory would have, being able to analyze blood and urine samples and also saliva swabs. In addition, it comes with the perks of being compact, wireless and compatible with any smartphone or tablet.”
Beyond sending healthcare missions, support from the Red Cross, Doctors without Borders and other similar projects aimed at making a difference in the lives of many sufferers, the scientific world has come up with another solution that addresses the problem of facilitating testing in order to establish a treatment plan as quickly as possible. The name of this solution is ApolloDx – Mobile Diagnostic Platform, a device which can offer high-accuracy test results in less than 10 minutes.
The diagnostic machine incorporates several functions a normal laboratory would have, being able to analyze blood and urine samples and also saliva swabs. In addition, it comes with the perks of being compact, wireless and compatible with any smartphone or tablet. The device is able to detect and process a full range of analytes (substances or chemical components that are of interest in an analytical procedure) such as ions, proteins, genes, peptides, drugs and whole cells, from samples that are placed on individual strips that are used for testing. The data collected after analysis can be then transferred to electronic medical records systems, a process through which the patient’s file can be constantly kept up to date. This is not the only advantage of this tracking system as the function can also be used in order to know in real time the rate in which a disease is spreading in case of an epidemic. In this way, outbreaks could be more efficiently contained and treated.
“The data collected after analysis can be then transferred to electronic medical records systems, a process through which the patient’s file can be constantly kept up to date.”
“So what physicians want is they want to be able to have the patient present, take a sample, do a diagnostic test and provide a treatment in one visit.” (Bill Pagels, Co-Chairman and Chief Scientific Officer, ApolloDx)
The ApolloDx system’s success rate has also been analyzed in terms of financial aspects and has proven to be able to lower the overall cost of testing and healthcare in general. The “on-spot” intervention rids the physician, as well as the patient, of unnecessary transportation costs and lost time from the moment a sample is taken to the moment when the results are in and a proper treatment plan can be discussed.
The first round of testing has been scheduled by the ApolloDx LLC in vitro mobile point-of-care diagnostic company to commence in Europe in 2017 with the help of visionary investors that believe in the device’s potential and the benefits it could bring to healthcare systems worldwide.
“At ApolloDx, we envision a very different future for diagnostics. Diagnosis directly with the patient, by giving them the result that they need and analysis by being able to review those results, to aggregate them, look at them, analyze them and come up with ways that we could look at healthcare differently. ”
“This isn’t just about medicine for the patient, this is about medicine for the world.” (Jared Bauer, Chief Executive Officer, ApolloDx)
Written by R.F.I